Healthcare Companies Converge on Morgan Stanley and Deutsche Bank Conferences With Growth Updates

A broad range of healthcare and biotech companies presented at two major industry gatherings on September 16, 2026: the Morgan Stanley 24th Annual Global Healthcare Conference and the Deutsche Bank 2026 Healthcare Summit. The presentations spanned therapeutics, managed care, and healthcare services, reflecting active investor engagement across the sector.

Among the companies appearing at the Morgan Stanley conference were Parabilis Medicines (PBLS), Surrozen (SRZN), Palisade Bio (PALI), Gubra A/S (GUBRF), and Enliven Therapeutics (ELVN), while Centene Corporation (CNC) and Aveanna Healthcare Holdings (AVAH) took the stage at the Deutsche Bank summit. Natera also presented at the global healthcare conference, with commentary highlighting a broadening of the company's growth profile.

In secondary market activity tied to the sector, DaVita HealthCare (DVA) bucked a broader market decline, closing at $193.86, up 1.55% on the session.